Literature DB >> 14656744

Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene.

Aaron Hamvas1, Lawrence M Nogee, Frances V White, Pamela Schuler, Brian P Hackett, Charles B Huddleston, Eric N Mendeloff, Fong-Fu Hsu, Susan E Wert, Linda W Gonzales, Michael F Beers, Philip L Ballard.   

Abstract

Mutations in the surfactant protein (SP)-C gene are responsible for familial and sporadic interstitial lung disease (ILD). The consequences of such mutations on pulmonary surfactant composition and function are poorly understood. To determine the effects of a mutation in the SP-C gene on surfactant, we obtained lung tissue at the time of transplantation from a 14-mo-old infant with progressive ILD. An in-frame 9-bp deletion spanning codons 91-93 in Exon 3 of the SP-C gene was present on one allele; neither parent carried this deletion. SP-C mRNA was present in normal size and amount. By immunofluorescence, proSP-C was aggregated within alveolar Type II cells in a compartment separate from SP-B. In airway surfactant, there was little or no mature SP-B or SP-C; SP-A content was increased. Minimum surface tension was increased (20 mN/m, normal < 5 mN/m). Type II cells contained normal and disorganized appearing lamellar bodies by electron microscopy. This spontaneous deletion on one allele of the SP-C gene was associated with sporadic ILD and abnormalities in surfactant composition and function. We propose that a dominant negative effect on surfactant protein metabolism and function results from aggregation of misfolded proSP-C and subsequent cell injury and inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656744     DOI: 10.1165/rcmb.2003-0323OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  26 in total

1.  Population and disease-based prevalence of the common mutations associated with surfactant deficiency.

Authors:  Tami H Garmany; Jennifer A Wambach; Hillary B Heins; Julie M Watkins-Torry; Daniel J Wegner; Kate Bennet; Ping An; Garland Land; Ola D Saugstad; Howard Henderson; Lawrence M Nogee; F Sessions Cole; Aaron Hamvas
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

Review 2.  Surfactant dysfunction.

Authors:  W Adam Gower; Lawrence M Nogee
Journal:  Paediatr Respir Rev       Date:  2011-03-05       Impact factor: 2.726

3.  Recombination as a mechanism for sporadic mutation in the surfactant protein-C gene.

Authors:  Amy D McBee; Daniel J Wegner; Christopher S Carlson; Jennifer A Wambach; Ping Yang; Hillary B Heins; Ola D Saugstad; Michelle A Trusgnich; Julie Watkins-Torry; Lawrence M Nogee; Howard Henderson; F Sessions Cole; Aaron Hamvas
Journal:  Pediatr Pulmonol       Date:  2008-05

4.  A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.

Authors:  Qing Yan; Yuan Quan; Huanhuan Sun; Xinmiao Peng; Zhengyun Zou; Joseph L Alcorn; Rick A Wetsel; Dachun Wang
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

Review 5.  The genetic approach in pulmonary fibrosis: can it provide clues to this complex disease?

Authors:  William E Lawson; James E Loyd
Journal:  Proc Am Thorac Soc       Date:  2006-06

6.  High-resolution computed tomography findings of thyroid transcription factor 1 deficiency (NKX2-1 mutations).

Authors:  Benjamin D LeMoine; Lorna P Browne; Deborah R Liptzin; Robin R Deterding; Csaba Galambos; Jason P Weinman
Journal:  Pediatr Radiol       Date:  2019-03-30

7.  Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Authors:  Donatella Peca; Renata Boldrini; Jan Johannson; Joseph T Shieh; Arianna Citti; Stefania Petrini; Teresa Salerno; Salvatore Cazzato; Raffaele Testa; Francesco Messina; Alfredo Onofri; Giovanna Cenacchi; Per Westermark; Nicola Ullmann; Nicola Ullman; Paola Cogo; Renato Cutrera; Olivier Danhaive
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

8.  Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism.

Authors:  Whitney B Eldridge; Qunyuan Zhang; Albert Faro; Stuart C Sweet; Pirooz Eghtesady; Aaron Hamvas; F Sessions Cole; Jennifer A Wambach
Journal:  J Pediatr       Date:  2017-02-16       Impact factor: 4.406

Review 9.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

Review 10.  Genetics and early detection in idiopathic pulmonary fibrosis.

Authors:  Rachel K Putman; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.